Impaired absorption of rifabutin by concomitant administration of didanosine

AIDS. 2001 Nov 9;15(16):2203-4. doi: 10.1097/00002030-200111090-00022.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • AIDS-Related Opportunistic Infections / drug therapy*
  • Anti-HIV Agents / administration & dosage
  • Anti-HIV Agents / pharmacokinetics*
  • Antibiotics, Antitubercular / administration & dosage
  • Antibiotics, Antitubercular / pharmacokinetics*
  • Didanosine / administration & dosage
  • Didanosine / pharmacokinetics*
  • Drug Interactions
  • Drug Therapy, Combination
  • HIV Infections / drug therapy
  • HIV-1
  • Humans
  • Intestinal Absorption
  • Male
  • Middle Aged
  • Mycobacterium Infections / drug therapy
  • Reverse Transcriptase Inhibitors / administration & dosage
  • Reverse Transcriptase Inhibitors / pharmacokinetics*
  • Rifabutin / administration & dosage
  • Rifabutin / pharmacokinetics*

Substances

  • Anti-HIV Agents
  • Antibiotics, Antitubercular
  • Reverse Transcriptase Inhibitors
  • Rifabutin
  • Didanosine